EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A potential risk factor associated with acute tumor lysis syndrome in dogs with multicentric lymphoma receiving chemotherapy

Hiroki Yamazaki, Konami Nagai, Yusuke Wada, Shunsuke Noguchi, Shushi Yamamoto, Toshikazu Sakai, Shidow Torisu

Journal of Veterinary Internal Medicine · 2026

DOI: 10.1093/jvimsj/aalaf088 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Veterinary Internal Medicine, 2026. Verfasst von Hiroki Yamazaki und 6 weiteren Autor:innen. Beteiligte Einrichtung: Companion Animal Internal Medicine, Department of Companion Animal Clinical Sciences, School of Veterinary Medicine, Rakuno Gakuen University, Ebetsu…. Hauptthemen laut MEDLINE: Tumor Lysis Syndrome, Dog Diseases, Antineoplastic Agents, Lymphoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Acute tumor lysis syndrome (ATLS) is caused by the rapid breakdown of tumor cells, leading to electrolyte imbalances and renal dysfunction. The risk of ATLS is particularly high in lymphoma, and therefore it is crucial to consider this risk when initiating chemotherapy. However, risk factors associated with ATLS in dogs remain largely unexplored. Hypothesis/Objectives Identify potential risk factors for ATLS in dogs with multicentric lymphoma. Animals A retrospective analysis was conducted on 24 dogs diagnosed with B-cell high-grade multicentric lymphoma that received chemotherapy.

Methods

Blood samples were collected before treatment and on days 3, 5, and 8 after treatment. Serum concentrations of uric acid, potassium, phosphorus, calcium, and creatinine were measured based on the Cairo-Bishop Criteria to classify cases as laboratory tumor lysis syndrome (LTLS) or clinical tumor lysis syndrome (CTLS). Clinical variables, including signalment, clinical signs, comorbidities, stage, chemotherapy agents, hematologic and biochemical findings, chemotherapy response, and clinical outcomes were compared between two groups: normal and LTLS/CTLS.

Results

Of 24 dogs, LTLS occurred in 5 (20.8%), whereas CTLS occurred in 2 (8.3%). The development of LTLS/CTLS was strongly associated with the initial administration of L-asparaginase, presence of chronic kidney disease (CKD), weight loss, and metabolic acidosis. However, no significant differences were observed between the normal and LTLS/CTLS groups regarding signalment, clinical signs, stage, CBC abnormality, and clinical outcomes. Conclusions and clinical importance Evaluating the four risk factors at the initiation of chemotherapy may help establish personalized prevention strategies for ATLS in dogs with multicentric lymphoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor Lysis SyndromeDog DiseasesAntineoplastic AgentsLymphomaLymphoma, B-CellAnimalsDogsRisk FactorsFemaleRetrospective StudiesMaleAsparaginase

Stichwörter der Autor:innen

L-asparaginasechronic kidney diseasemetabolic acidosisweight loss

Substanzen

Antineoplastic AgentsAsparaginase

Autor:innen und Institutionen

  • Companion Animal Internal Medicine, Department of Companion Animal Clinical Sciences, School of Veterinary Medicine, Rakuno Gakuen University, Ebetsu, Hokkaido, 069-8501, Japan.
  • The Veterinary Medical Center, Graduate School of Life and Environmental Sciences, Osaka Metropolitan University, 1-58 Rinku-Oraikita, Izumisano 598-8531, Japan.
  • Department of Oncology, Osaka Hospital, Japan Animal Referral Medical Center, 3-14-7 Senbanishi, Minoo-shi, Osaka 562-0036, Japan.
  • Companion Animal Veterinary Surgery, Department of Companion Animal Clinical Sciences, School of Veterinary Medicine, Rakuno Gakuen University, 582-1 Bunkyodai-Midorimachi, Ebetsu, Hokkaido 069-8501, Japan.

Zitieren

APA

Yamazaki, H., Nagai, K., Wada, Y., Noguchi, S., Yamamoto, S., Sakai, T., & Torisu, S. (2026). A potential risk factor associated with acute tumor lysis syndrome in dogs with multicentric lymphoma receiving chemotherapy. Journal of Veterinary Internal Medicine. https://doi.org/10.1093/jvimsj/aalaf088

Vancouver

Yamazaki H, Nagai K, Wada Y, Noguchi S, Yamamoto S, Sakai T, et al. A potential risk factor associated with acute tumor lysis syndrome in dogs with multicentric lymphoma receiving chemotherapy. Journal of Veterinary Internal Medicine. 2026. doi:10.1093/jvimsj/aalaf088

BibTeX
@article{Yamazaki2026,
  author = {Yamazaki, Hiroki and Nagai, Konami and Wada, Yusuke and Noguchi, Shunsuke and Yamamoto, Shushi and Sakai, Toshikazu and Torisu, Shidow},
  title = {A potential risk factor associated with acute tumor lysis syndrome in dogs with multicentric lymphoma receiving chemotherapy},
  journal = {Journal of Veterinary Internal Medicine},
  year = {2026},
  doi = {10.1093/jvimsj/aalaf088}
}
Kostenlos starten →